ClinicalTrials.gg
Sign In

Anthrax clinical trials

The registry lists 75 studies for Anthrax across more than 10 countries. 12 are recruiting or about to start. 58 of them are mainly about Anthrax (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-20.

Get an email when these change. Save the Anthrax studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
54
Not yet recruiting
8
Terminated
4
Recruiting
4
Withdrawn
2
Active, not recruiting
1

Phase

Phase 1
28
Phase 2
17
Phase 4
7
Phase 3
3
Early Phase 1
1

Where

United States
47
France
4
Japan
3
Korea, Republic of
2
United Kingdom
2
Taiwan
1

Who runs them

Emergent BioSolutions (14) · National Institute of Allergy and Infectious Diseases (NIAID) (7) · Elusys Therapeutics (4) · Bayer (3) · PharmAthene, Inc. (3) · Biomedical Advanced Research and Development Authority (2) · Taichung Veterans General Hospital (2) · Centre Hospitalier Universitaire de Saint Etienne (2)

What is being tested here

Drugs under test in Anthrax studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Charcoal208
Obiltoxaximab105
Canagliflozin101
AV7909017
Biothrax015
MDX-1303003
Ciprofloxacin002
Rivaroxaban002
Doxycycline001
Glyburide001

Coming up

0phase 3 studies under way
3studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3

Who these studies take

Of the 4 Anthrax studies recruiting now, 4 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 1 (25%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 4
AgeWomenMen
101 (25%)1 (25%)
183 (75%)3 (75%)
304 (100%)4 (100%)
404 (100%)4 (100%)
504 (100%)4 (100%)
654 (100%)4 (100%)
754 (100%)4 (100%)
854 (100%)4 (100%)

Across all 75 studies, recruiting or not: 57% stop at 75 or younger and 56% at 65; 23% take children; 0% are for women only and 5% for men only; 63% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Anthrax studies take

Of 11 phase 1 interventional studies under Anthrax, half reached primary completion within 14 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 114 mo8–18 · 11 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 75. Browse all 75 → or search them.